Steven Johnson syndrome in a 14-year-old patient due to Lamotrigine consumption. A case report
DOI:
https://doi.org/10.61708/nxf7w764Keywords:
Stevens-Johnson syndrome, drug eruptions, lamotrigine, pediatrics, mucous membrane, intravenous immunoglobulinAbstract
Stevens-Johnson Syndrome (SJS) is a serious adverse drug reaction characterized by high mortality and lack of effective treatments. This study presents a clinical case of a 14-year-old male patient who developed SJS after administration of lamotrigine. The patient presented erythema, blisters, and mucosal involvement, which led to hospitalization. A multidisciplinary management was implemented, including drug discontinuation, administration of corticosteroids and immunoglobulin, which led to a favorable recovery. The literature review demonstrated variations in the clinical presentation and management of SJS, highlighting the importance of close monitoring in the use of lamotrigine, especially in pediatric patients, to prevent severe adverse reactions. This case illustrates the need for rigorous protocols and preventive strategies in public health.
Downloads
References
García A, Mateo N, Granda M, Valencia A, Aguabi S. Urgencias dermatológicas. Revisión clínica de: eritrodermia exfoliativa y del síndrome de stevens-johnson. Ciencia Latina Revista Científica Multidisciplinar. 7 de febrero de 2023;7(1):2953-78. https://doi.org/10.37811/cl_rcm.v7i1.4636 DOI: https://doi.org/10.37811/cl_rcm.v7i1.4636
Urias L. Síndrome Stevens Jonhson: reporte de caso clínico. Revista de Sanidad Militar. 28 de septiembre de 2023;77(3):1-9. https://doi.org/10.56443/rsm.v77i3.308 DOI: https://doi.org/10.56443/rsm.v77i3.308
Lázaro Y, Vargas L, Moreno G. Síndrome de Steven Johnson: Caso clínico. Revista argentina de dermatología. marzo de 2021;102(1):31-40.
Salazar J, Jiménez A, Agüero A. Sindrome de Stevens-Johnson y Necrólisis Epidérmica Tóxica. Revista Medica Sinergia. 1 de enero de 2020;5(1):e308- e308. https://doi.org/10.31434/rms.v5i1.308 DOI: https://doi.org/10.31434/rms.v5i1.308
González A, Gálvez R, Maya D, Chávez D. Síndrome de Stevens Johnson- necrólisis epidérmica tóxica. Anales Médicos de la Asociación Médica del Centro Médico ABC. 2022;67(2):137-41. https://doi.org/10.35366/106029 DOI: https://doi.org/10.35366/106029
Edinoff A, Nguyen L, Fitz M, Crane E, Lewis K, Pierre S, et al. Lamotrigine and Stevens-Johnson Syndrome Prevention. Psychopharmacology Bulletin. 16 de marzo de 2021;51(2):96-114.
Eli̇Açik S. Side Effect of Lamotrigine in the Emergency Department; Stevens-Johnson Syndrome. Anatolian Journal of Emergency Medicine. 9 de marzo de 2022;5(1):31-3. https://doi.org/10.54996/anatolianjem.1015618 DOI: https://doi.org/10.54996/anatolianjem.1015618
Núñez I, Stanziola F, Benedito V. Progresión rápida de síndrome de Stevens-Johnson a necrólisis epidérmica tóxica secundario a lamotrigina. Revista Médico Científica. 11 de junio de 2020;33(1):8-15. https://doi.org/10.37416/rmc.v33i1.538 DOI: https://doi.org/10.37416/rmc.v33i1.538
Espinosa E, Piña S, Espinosa K, Tun J, Calderón A. Steven-Johnson Syndrome Induced by Lamotrigine and Valproic Acid in a Pediatric Patient: A Case Report. Cureus. 2023;15(7):e41267.
Oliveira A, Lopes C, Oliveira G, Caetano J. Manejo da síndrome de Stevens-Johnson/Necrólise Epidérmica Tóxica, secundária ao uso de lamotrigina: un relato de caso. Revista Ibero-Americana de Humanidades, Ciências e Educação. 29 de septiembre de 2023;9(9):1055-68. https://doi.org/10.51891/rease.v9i9.11229 DOI: https://doi.org/10.51891/rease.v9i9.11229
Bushra U. A Case Report: Lamotrigine Induced Steven Johnson Syndrome. Future Journal of Pharmaceuticals and Health Sciences. 2021;1(4):215-8. https://doi.org/10.26452/fjphs.v1i4.202 DOI: https://doi.org/10.26452/fjphs.v1i4.202
Cabrerizo M, Castro C, Castaño C, Valero P, García A, Pérez B. Reunión Sociedad Española de urgencias de pediatría. 2022. Síndrome de Stevens- Johnson por Lamotrigina. Disponible en: https://seup.org/pdf_public/reuniones/2022/37/PD178.pdf
Yang L, Shou YH, Li F, Zhu XH, Yang YS, Xu JH. Intravenous Immunoglobulin Combined With Corticosteroids for the Treatment of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Propensity- Matched Retrospective Study in China. Front Pharmacol [Internet]. 18 de enero de 2022 [citado 14 de abril de 2025];12. Disponible en: https://www.frontiersin.orghttps://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.750173/full https://doi.org/10.3389/fphar.2021.750173 DOI: https://doi.org/10.3389/fphar.2021.750173
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Copyright: © Los autores. Publicado por Gaceta Médica JBG.
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
